MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $317,000 | +24.8% | 124,901 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $254,000 | +53.9% | 124,901 | +63.9% | 0.00% | – |
| Q4 2019 | $165,000 | +38.7% | 76,193 | -1.4% | 0.00% | – |
| Q3 2019 | $119,000 | -62.9% | 77,258 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $321,000 | +4.9% | 77,258 | +5.7% | 0.00% | 0.0% |
| Q1 2019 | $306,000 | +91.2% | 73,111 | +31.2% | 0.00% | – |
| Q4 2018 | $160,000 | -71.3% | 55,718 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $557,000 | +41.4% | 55,718 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $394,000 | – | 55,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 5,016,164 | $10,835,000 | 2.15% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,836,000 | 1.91% |
| Asymmetry Capital Management, L.P. | 354,853 | $766,000 | 1.37% |
| Lion Point Capital, LP | 6,374,740 | $13,769,000 | 1.28% |
| Granite Point Capital Management, L.P. | 2,700,000 | $5,832,000 | 0.91% |
| VHCP Management II, LLC | 1,486,676 | $3,211,000 | 0.85% |
| Boxer Capital, LLC | 4,800,000 | $10,368,000 | 0.59% |
| Avoro Capital Advisors LLC | 6,200,000 | $13,392,000 | 0.39% |
| 683 Capital Management, LLC | 925,382 | $1,999,000 | 0.23% |
| Islet Management, LP | 875,000 | $1,890,000 | 0.18% |